Prudential Financial Inc. Sells 10,083 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Prudential Financial Inc. decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 12.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,126 shares of the company's stock after selling 10,083 shares during the quarter. Prudential Financial Inc. owned approximately 0.05% of Henry Schein worth $5,109,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of HSIC. Smartleaf Asset Management LLC boosted its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. CIBC Asset Management Inc increased its position in Henry Schein by 1.0% in the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC raised its stake in shares of Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares during the last quarter. Central Pacific Bank Trust Division raised its stake in shares of Henry Schein by 2.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock valued at $706,000 after acquiring an additional 200 shares during the last quarter. Finally, Sanctuary Advisors LLC lifted its holdings in shares of Henry Schein by 5.0% during the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after purchasing an additional 203 shares during the period. Institutional investors own 96.62% of the company's stock.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Stock Down 1.7 %

HSIC traded down $1.12 during midday trading on Friday, hitting $65.47. The company had a trading volume of 2,362,489 shares, compared to its average volume of 1,585,938. The company has a market capitalization of $8.13 billion, a price-to-earnings ratio of 26.94, a PEG ratio of 2.13 and a beta of 0.84. The stock's 50 day moving average price is $73.96 and its 200 day moving average price is $72.58. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52 week low of $63.00 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.66 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Jefferies Financial Group raised their target price on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and raised their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Finally, Wells Fargo & Company assumed coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target on the stock. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.